X4 Pharmaceuticals, Inc.
CANCER SERUM BIOMARKERS AND METHODS OF USE THEREOF

Last updated:

Abstract:

The present invention relates, in part, to certain serum biomarkers and use thereof in methods for treating cancer, such as in evaluating and/or in additional methods such as predicting patient responses to treatment with a CXCR4 inhibitor optionally in combination with a immunotherapeutic agent, in patients with a cancer such as melanoma, including resectable and unresectable melanoma.

Status:
Application
Type:

Utility

Filling date:

12 Apr 2019

Issue date:

28 Jan 2021